Sawtooth Solutions, LLC Exelixis, Inc. Transaction History

Sawtooth Solutions, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 12, 2020	SELL	$15.15 - $18.89 $215,978 - $269,295	-14,256 Closed	0 $0
Q3 2019 Nov 07, 2019	SELL	$17.68 - $22.65 $388 - $498	-22 Reduced 0.15%	14,256 $252,000
Q2 2019 Aug 08, 2019	SELL	$18.93 - $24.75 $52,644 - $68,829	-2,781 Reduced 16.3%	14,278 $305,000
Q1 2019 May 10, 2019	BUY	$19.6 - $24.76 $334,356 - $422,380	17,059 New	17,059 $406,000

564

251M

1.45M

1.13M

Ticker EXEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 321,832,000
Market Cap $11.3B
Description
Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...

Get notified when there are updates to the investment portfolio of Sawtooth Solutions, LLC, based on Form 13F filings with the SEC.

Stay updated on Sawtooth Solutions, LLC with notifications on news.